Back to Search
Start Over
New drug approvals in acute myeloid leukemia: what's the best end point?
- Source :
-
Leukemia [Leukemia] 2016 Mar; Vol. 30 (3), pp. 521-5. Date of Electronic Publication: 2015 Dec 18. - Publication Year :
- 2016
- Subjects :
- Fusion Proteins, bcr-abl genetics
Fusion Proteins, bcr-abl metabolism
Gene Expression
Humans
Leukemia, Myeloid, Acute diagnosis
Leukemia, Myeloid, Acute mortality
Leukemia, Myeloid, Acute pathology
Neoplasm, Residual
Prognosis
Quality of Life
Remission Induction
Survival Analysis
United States
Biomarkers, Pharmacological analysis
Bone Marrow Transplantation
Drug Approval legislation & jurisprudence
Drugs, Investigational therapeutic use
Leukemia, Myeloid, Acute therapy
Subjects
Details
- Language :
- English
- ISSN :
- 1476-5551
- Volume :
- 30
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- Leukemia
- Publication Type :
- Report
- Accession number :
- 26677969
- Full Text :
- https://doi.org/10.1038/leu.2015.262